DITTO Raises €5.2M for Menstrual Health
DITTO raised €5.2M to expand research-led menstrual-health products and community support.
Women’s health is still full of large, under-researched categories hiding in plain sight.
What happened
UK menstrual-health company DITTO raised a €5.2 million seed round led by FoodLabs, with support from EKA Ventures and angel investors.
The company plans to expand research projects, its science-led supplement range and its community reach. Its broader pitch is to tackle gaps in menstrual health with a combination of research, targeted products and user education.
Why it matters
Menstrual health has often been treated as a narrow consumer category rather than a serious healthcare and research market. That has left major gaps in data, product development and clinical understanding.
DITTO is interesting because it is trying to build around a specific underserved area rather than selling generic wellness. The risk is that supplement-led healthtech can easily become shallow if the evidence base is weak, so the research component will matter.
The bigger picture
Women’s health remains one of the clearer examples of venture capital finding markets that traditional healthcare systems have under-prioritised. The strongest companies in this space will need to combine brand trust, scientific credibility and practical distribution.